-
- Shop
- Health Solutions
- Brands We Carry
Item added to your cart
Heart disease is the leading cause of death in the United States, affecting both men and women alike. Yet, it rarely develops overnight. Decades before a heart attack or stroke, changes occur within the arteries that silently damage the vascular system. These early warning signs can now be detected and reversed with advanced testing long before symptoms appear.
Recent breakthroughs in vascular biology allow us to see what is happening not just inside the arteries, but within their walls where plaque and inflammation begin. Traditional risk factors such as cholesterol, blood pressure, and age tell only part of the story. Genetics, metabolism, and lifestyle play an equally powerful role.
By combining advanced diagnostics with genetic and metabolic insights, we can assess your complete cardiovascular risk. This comprehensive approach identifies where you are on the cardiometabolic spectrum and helps us design precise preventive care to restore vascular health and protect your heart for the long term.
Advanced CardioVascular screening also tests for other biomarkers involved in the disease process. These are tests that give invaluable insight into levels of inflammation, oxidative stress, plaque development and stability. One test in particular, the PULS ( Protein Unstable Lesion Signature) test can quantify your risk for a cardiovascular event in the next 5 years. It is an invaluable tool that can help detect severe disease otherwise missed, as well as to monitor disease resolution and efficacy of treatment programs.
Traditional and even advanced markers as above are only telling half the story. Genetics play a major role in our risk of developing heart disease. The Cardia-X test from Vibrant-America tests for common genetic SNPs (single changes in genes that can change the function of the gene) that are associated with increased predisposition to numerous medical conditions associated with heart disease – including risk for high blood pressure and blood clot formation. The genes tested are specific to risk for heart disease, and it allows for
Determining where you are on the spectrum of heart disease is essential. It can mean the difference between addressing a nearly completely blocked artery under a very controlled setting vs in an emergent active heart heart attack situation. All of these parameters tested are modifiable – there is an intervention that can be implemented to address the cause and reverse the process of cardiometabolic disease.
About one-third of Americans have cholesterol levels above the healthy range and are often prescribed statins or other medications to bring those levels down. However, new research shows that cholesterol numbers alone are not the most accurate indicators of heart disease or cardiovascular risk. The conventional approach focuses on lowering LDL cholesterol and triglycerides with medication, without addressing the underlying causes of imbalance.
For decades, terms like high cholesterol, hypercholesterolemia, and hyperlipidemia have been used to describe excess cholesterol in the body. Today, the term dyslipidemia provides a more accurate understanding, referring to an imbalance in the types and functions of cholesterol. Cholesterol itself is not harmful; it is essential for many vital processes. The key is maintaining optimal levels and balance among the different types.
Lowering LDL, or "bad" cholesterol, does not always reduce the risk of a heart attack. Statin medications such as Lipitor and Crestor reduce that risk by only about 27 percent, and nearly half of those hospitalized for a heart attack have normal cholesterol levels. This reveals that heart health depends on more than total cholesterol numbers.
Connect with us and tell us how we can help as you begin on your path towards improved health!
